152 related articles for article (PubMed ID: 32282370)
1. In-vitro and in-vivo investigations into the carbene-gold anticancer drug candidates NHC*-Au-SCSNMe2 and NHC*-Au-S-GLUC against advanced prostate cancer PC3.
Walther W; Althagafi D; Curran D; O'Beirne C; Mc Carthy C; Ott I; Basu U; Büttner B; Sterner-Kock A; Müller-Bunz H; Sánchez-Sanz G; Zhu X; Tacke M
Anticancer Drugs; 2020 Aug; 31(7):672-683. PubMed ID: 32282370
[TBL] [Abstract][Full Text] [Related]
2. Preparation of Titanocene-Gold Compounds Based on Highly Active Gold(I)-N-Heterocyclic Carbene Anticancer Agents: Preliminary in vitro Studies in Renal and Prostate Cancer Cell Lines.
Curado N; Giménez N; Miachin K; Aliaga-Lavrijsen M; Cornejo MA; Jarzecki AA; Contel M
ChemMedChem; 2019 Jun; 14(11):1086-1095. PubMed ID: 30924298
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xenografts.
Cattaruzza L; Fregona D; Mongiat M; Ronconi L; Fassina A; Colombatti A; Aldinucci D
Int J Cancer; 2011 Jan; 128(1):206-15. PubMed ID: 20209498
[TBL] [Abstract][Full Text] [Related]
4. N-heterocyclic carbenes (NHC) with 1,2,4-oxadiazole-substituents related to natural products: synthesis, structure and potential antitumor activity of some corresponding gold(I) and silver(I) complexes.
Maftei CV; Fodor E; Jones PG; Freytag M; Franz MH; Kelter G; Fiebig HH; Tamm M; Neda I
Eur J Med Chem; 2015 Aug; 101():431-41. PubMed ID: 26185007
[TBL] [Abstract][Full Text] [Related]
5. Rapid Synthesis and Antiproliferative Properties of Polyazamacrocycle-Based Bi- and Tetra-Gold(I) Phosphine Dithiocarbamate Complexes.
Florès O; Velic D; Mabrouk N; Bettaïeb A; Tomasoni C; Robert JM; Paul C; Goze C; Roussakis C; Bodio E
Chembiochem; 2019 Sep; 20(17):2255-2261. PubMed ID: 30969460
[TBL] [Abstract][Full Text] [Related]
6. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
Ronconi L; Giovagnini L; Marzano C; Bettìo F; Graziani R; Pilloni G; Fregona D
Inorg Chem; 2005 Mar; 44(6):1867-81. PubMed ID: 15762713
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity, qualitative structure-activity relationship (QSAR), and anti-tumor activity of bismuth dithiocarbamate complexes.
Li H; Lai CS; Wu J; Ho PC; de Vos D; Tiekink ER
J Inorg Biochem; 2007 May; 101(5):809-16. PubMed ID: 17363061
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of ester- and amide-functionalized imidazolium salts and related water-soluble coinage metal N-heterocyclic carbene complexes.
Pellei M; Gandin V; Marinelli M; Marzano C; Yousufuddin M; Dias HV; Santini C
Inorg Chem; 2012 Sep; 51(18):9873-82. PubMed ID: 22946642
[TBL] [Abstract][Full Text] [Related]
10. Gold(I) NHC Complexes: Antiproliferative Activity, Cellular Uptake, Inhibition of Mammalian and Bacterial Thioredoxin Reductases, and Gram-Positive Directed Antibacterial Effects.
Schmidt C; Karge B; Misgeld R; Prokop A; Franke R; Brönstrup M; Ott I
Chemistry; 2017 Feb; 23(8):1869-1880. PubMed ID: 27865002
[TBL] [Abstract][Full Text] [Related]
11. Gold(I) N-heterocyclic carbene complexes with naphthalimide ligands as combined thioredoxin reductase inhibitors and DNA intercalators.
Meyer A; Oehninger L; Geldmacher Y; Alborzinia H; Wölfl S; Sheldrick WS; Ott I
ChemMedChem; 2014 Aug; 9(8):1794-800. PubMed ID: 24803348
[TBL] [Abstract][Full Text] [Related]
12. Gold(I) complex of N,N'-disubstituted cyclic thiourea with in vitro and in vivo anticancer properties-potent tight-binding inhibition of thioredoxin reductase.
Yan K; Lok CN; Bierla K; Che CM
Chem Commun (Camb); 2010 Nov; 46(41):7691-3. PubMed ID: 20623063
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols.
Hickey JL; Ruhayel RA; Barnard PJ; Baker MV; Berners-Price SJ; Filipovska A
J Am Chem Soc; 2008 Sep; 130(38):12570-1. PubMed ID: 18729360
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization and anticancer activity of gold(I) complexes that contain tri-tert-butylphosphine and dialkyl dithiocarbamate ligands.
Altaf M; Monim-ul-Mehboob M; Seliman AA; Sohail M; Wazeer MI; Isab AA; Li L; Dhuna V; Bhatia G; Dhuna K
Eur J Med Chem; 2015 May; 95():464-72. PubMed ID: 25841201
[TBL] [Abstract][Full Text] [Related]
15. New comprehensive studies of a gold(III) Dithiocarbamate complex with proven anticancer properties: Aqueous dissolution with cyclodextrins, pharmacokinetics and upstream inhibition of the ubiquitin-proteasome pathway.
Tomasello MF; Nardon C; Lanza V; Di Natale G; Pettenuzzo N; Salmaso S; Milardi D; Caliceti P; Pappalardo G; Fregona D
Eur J Med Chem; 2017 Sep; 138():115-127. PubMed ID: 28651154
[TBL] [Abstract][Full Text] [Related]
16. Halo and Pseudohalo Gold(I)-NHC Complexes Derived from 4,5-Diarylimidazoles with Excellent
Bian M; Fan R; Jiang G; Wang Y; Lu Y; Liu W
J Med Chem; 2020 Sep; 63(17):9197-9211. PubMed ID: 32787098
[TBL] [Abstract][Full Text] [Related]
17. Strong inhibition of thioredoxin reductase by highly cytotoxic gold(I) complexes. DNA binding studies.
Ortego L; Cardoso F; Martins S; Fillat MF; Laguna A; Meireles M; Villacampa MD; Gimeno MC
J Inorg Biochem; 2014 Jan; 130():32-7. PubMed ID: 24157605
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization, and in vitro studies of bis[1,3-diethyl-4,5-diarylimidazol-2-ylidene]gold(I/III) complexes.
Liu W; Bensdorf K; Proetto M; Hagenbach A; Abram U; Gust R
J Med Chem; 2012 Apr; 55(8):3713-24. PubMed ID: 22424185
[TBL] [Abstract][Full Text] [Related]
19. Novel Anticancer NHC*-Gold(I) Complexes Inspired by Lepidiline A.
Curran D; Müller-Bunz H; Bär SI; Schobert R; Zhu X; Tacke M
Molecules; 2020 Jul; 25(15):. PubMed ID: 32751607
[No Abstract] [Full Text] [Related]
20. Enhanced anti-cancer activities of a gold(III) pyrrolidinedithiocarbamato complex incorporated in a biodegradable metal-organic framework.
Sun RW; Zhang M; Li D; Li M; Wong AS
J Inorg Biochem; 2016 Oct; 163():1-7. PubMed ID: 27387867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
